Nicholas Grund
CIK 1661887 · Chief Commercial Officer · last filed 2026-02-04
Nicholas Grund is a Chief Commercial Officer who has filed 12 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing shows the insider sold $117.9K of AKBA on Feb 4, 2026. Across all open-market trades the lifetime net is −$234.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $519.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$519.3K
2
12
-$234.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKBA | Chief Commercial Officer | 561,750 | $0.92 | $519.3K | -$234.7K | 4 | 2026-02-04 |
| AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Chief Commercial Officer | 84,805 | — | — | $0 | 8 | 2019-03-05 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-04 | AKBA | Sell (S) | −84,829 | -$117.9K | EDGAR |
| 2026-02-03 | AKBA | Grant (A) | +204,000 | $0 | EDGAR |
| 2025-02-04 | AKBA | Mixed | +139,279 | -$116.8K | EDGAR |
| 2024-02-02 | AKBA | Grant (A) | +303,300 | $0 | EDGAR |
| 2019-03-05 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −982 | -$14.5K | EDGAR |
| 2019-02-27 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Grant (A) | +24,000 | $0 | EDGAR |
| 2019-02-26 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −982 | -$15.2K | EDGAR |
| 2019-01-08 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −3,555 | -$57.6K | EDGAR |
| 2018-03-06 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Mixed | +17,807 | -$88.1K | EDGAR |
| 2017-05-10 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −3,483 | -$64.6K | EDGAR |